Author/Authors :
Chu، نويسنده , , William W. and Kuchulakanti، نويسنده , , Pramod K. and Torguson، نويسنده , , Rebecca Y. Wang، نويسنده , , Betty and Clavijo، نويسنده , , Leonardo C. and Suddath، نويسنده , , William O. and Pichard، نويسنده , , Augusto D. and Satler، نويسنده , , Lowell F. and Kent، نويسنده , , Kenneth M. and Waksman، نويسنده , , Ron، نويسنده ,
Abstract :
Sirolimus-eluting stent (SES) and paclitaxel-eluting stent (PES) implantation for the treatment of single coronary lesions has proved to be effective and durable. However, the safety and efficacy of overlapping drug-eluting stents for the treatment of long lesions have not been well established. In total, 114 patients who received overlapping drug-eluting stents were identified, 55 of whom received overlapping SESs and 59 received overlapping PESs. Baseline clinical and angiographic characteristics were balanced. In-hospital complications were similar between the 2 groups. At 30-day and 6-month follow-ups, all clinical outcomes were also similar. In addition, the event-free survival rate was comparable (p = 0.71). Implantation of overlapping drug-eluting stents for the treatment of long, native coronary lesions is feasible and effective. In conclusion, in this observational study, clinical outcomes appeared similar in patients treated with overlapping SES implantation compared with those treated with overlapping PES implantation.
